Neurothrombectomy Devices Sales

Neurothrombectomy Devices Sales Market Outlook

The global neurothrombectomy devices market was valued at approximately USD 1.5 billion in 2023 and is projected to reach around USD 2.5 billion by 2035, growing at a compound annual growth rate (CAGR) of approximately 6.5% during the forecast period. This growth can be attributed to the increasing prevalence of acute ischemic strokes, advancements in thrombectomy technologies, and a growing awareness of the benefits of prompt and effective stroke care. Additionally, the rising geriatric population, who are at higher risk for stroke-related incidents, along with the increasing investment in healthcare infrastructure, particularly in developing regions, are significant factors driving market growth. The shift towards minimally invasive surgical procedures also plays a crucial role in the adoption of neurothrombectomy devices, further propelling the market forward.

Growth Factor of the Market

The growth of the neurothrombectomy devices market is significantly influenced by several factors that are reshaping the landscape of stroke management. First, technological advancements have led to the development of innovative devices that offer improved efficacy and safety profiles in the treatment of acute ischemic strokes. These innovations include enhanced mechanical and aspiration devices that can remove thrombi with greater precision while minimizing the risk of complications. Second, the increasing prevalence of lifestyle-related health issues and conditions such as hypertension, diabetes, and obesity, which are known risk factors for stroke, has led to a higher incidence of stroke cases, thereby increasing the demand for neurothrombectomy interventions. Third, the establishment of robust healthcare policies and programs aimed at improving stroke care and patient outcomes is prompting widespread adoption of neurothrombectomy devices across healthcare facilities. Furthermore, ongoing clinical research and trials are constantly validating the effectiveness of these devices, fostering greater trust within the medical community. Lastly, the rising awareness among healthcare professionals regarding the importance of timely intervention in stroke management is contributing to the growth of the market.

Key Highlights of the Market

• Rapid advancements in neurothrombectomy technologies improving intervention outcomes.
• Increasing prevalence of acute ischemic strokes driving device demand.
• Rising geriatric population susceptible to stroke incidents.
• Growing focus on minimally invasive treatments enhancing surgical procedures.
• Emerging markets witnessing significant investments in healthcare infrastructure.

By Product Type

Mechanical Devices:

Mechanical devices are an essential category within the neurothrombectomy devices market, specifically designed to physically remove thrombi causing disruptions in blood flow to the brain. These devices utilize advanced mechanisms such as clot retrieval and fragmentation to ensure the effective restoration of blood circulation. The rising incidence of acute ischemic strokes is propelling the demand for these devices, as they provide immediate and effective treatment options for patients experiencing strokes. The advancements in mechanical devices have facilitated their usage in complex cases where traditional treatment methods may not provide optimal outcomes. Moreover, the integration of real-time imaging technologies with mechanical devices enhances procedural accuracy, thereby improving patient satisfaction and outcomes. The ongoing research and development aimed at refining the designs and functionalities of mechanical devices are further expected to boost the market growth.

Aspiration Devices:

Aspiration devices represent a pivotal segment of the neurothrombectomy devices market, functioning through the principle of suction to remove thrombus materials from cerebral vasculature. These devices are particularly valuable in treating large vessel occlusions, where rapid restoration of blood flow is critical. The increasing preference for aspiration techniques, owing to their minimally invasive nature and reduced complication rates, is contributing significantly to their market growth. Furthermore, technological advancements in aspiration devices, such as enhanced catheter designs and improved suction capabilities, are facilitating their adoption in clinical settings. The rise in clinical evidence supporting the efficacy of aspiration devices in acute ischemic stroke management is further strengthening their market position. As healthcare professionals continue to emphasize the importance of rapid intervention in stroke care, the demand for aspiration devices is expected to soar.

Stent Retrievers:

Stent retrievers are a specialized type of neurothrombectomy device designed to capture and remove thrombi from occluded blood vessels. This type of device plays a critical role in endovascular stroke treatment, particularly in cases involving large vessel occlusions. Stent retrievers are favored for their ability to achieve high recanalization rates and improve patient outcomes significantly. The design of these devices allows for the deployment of a stent that expands within the vessel and captures the clot, which can then be extracted. The growing body of clinical evidence supporting the efficacy of stent retrievers in acute ischemic stroke treatment is driving their adoption among healthcare practitioners. Furthermore, continuous innovations in the design and technology of stent retrievers, aimed at enhancing ease of use and effectiveness, are expected to bolster their market growth in the coming years.

Suction Devices:

Suction devices are a vital component of neurothrombectomy procedures, utilizing negative pressure to extract thrombi from the vascular system. Their importance is underscored by their ability to quickly remove blood clots, thus restoring blood flow and minimizing brain damage during acute ischemic strokes. The efficiency of these devices is complemented by the integration of advanced imaging technologies that guide their placement and operation during procedures. As the demand for rapid and effective stroke interventions rises, suction devices are becoming increasingly prevalent in hospitals and surgical centers. Furthermore, the growing body of evidence supporting the use of suction devices in clinical practice is fostering greater clinician confidence, which is essential for driving their adoption. The continuous evolution of suction technology is expected to enhance performance, leading to even wider acceptance in the neurothrombectomy landscape.

Balloon Guide Catheters:

Balloon guide catheters are specialized devices used to facilitate neurothrombectomy procedures by providing a controlled pathway for the delivery of aspiration or mechanical devices. These catheters are equipped with inflatable balloons that can occlude blood flow, allowing for more effective thrombus removal while minimizing blood loss during the procedure. The growing emphasis on precision in stroke management has led to an increased adoption of balloon guide catheters among healthcare professionals. Their ability to improve procedural efficiency and patient outcomes significantly contributes to their importance in the neurothrombectomy devices market. Enhanced designs and materials are continuously being developed to improve the efficacy and safety of balloon guide catheters. As medical professionals increasingly recognize the advantages offered by these devices, their market presence is anticipated to expand.

By Application

Acute Ischemic Stroke:

The acute ischemic stroke application segment is the most significant within the neurothrombectomy devices market, accounting for a substantial share due to the high incidence of this condition. Acute ischemic strokes occur when a blood clot obstructs the flow of blood to the brain, necessitating immediate intervention. The use of neurothrombectomy devices in this application is critical for restoring blood flow and minimizing neurological damage. The increasing recognition of the importance of rapid intervention is driving the demand for neurothrombectomy devices specifically designed for treating acute ischemic strokes. Moreover, ongoing clinical trials and studies demonstrating the effectiveness of these devices in improving patient outcomes are enhancing their adoption in clinical practice. The segment is expected to witness significant growth as awareness regarding acute stroke management continues to rise among healthcare providers and patients alike.

Chronic Stroke:

Chronic stroke management is an emerging application segment within the neurothrombectomy devices market, focusing on treating patients with persistent symptoms or complications resulting from previous strokes. The need for effective solutions to manage chronic stroke patients is becoming increasingly apparent, as they often experience ongoing health issues and reduced quality of life. Neurothrombectomy devices can play a pivotal role in addressing complications associated with chronic strokes, such as recurrent thrombus formation. The growing understanding of the long-term impacts of stroke and the importance of comprehensive care are driving interest in devices that can provide effective interventions for chronic stroke patients. As more clinical evidence supporting the use of neurothrombectomy devices in chronic cases becomes available, this segment is poised for considerable growth in the coming years.

By End User

Hospitals:

Hospitals are the primary end users of neurothrombectomy devices, as they are equipped to handle acute medical emergencies such as strokes. The presence of specialized stroke care units and interventional radiology departments allows hospitals to perform complex procedures involving neurothrombectomy devices effectively. The increasing incidence of strokes and the necessity for immediate care are propelling the demand for these devices in hospitals. Hospitals are also investing in advanced technologies and training for medical personnel to ensure the best possible outcomes for stroke patients. Furthermore, the growing emphasis on comprehensive stroke care is driving hospitals to enhance their capabilities, thereby increasing the adoption of neurothrombectomy devices. As healthcare systems continue to evolve and improve their response to stroke emergencies, the hospital segment is expected to sustain its dominance in the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as an important end user of neurothrombectomy devices, primarily due to their focus on outpatient care and minimally invasive procedures. With the increasing trend towards outpatient management of stroke patients, ASCs are being equipped with the necessary technologies and expertise to perform neurothrombectomy procedures effectively. The adoption of neurothrombectomy devices within ASCs is driven by the convenience they offer to patients, as they allow for quicker recovery times and reduced hospital stays. Moreover, the cost-effectiveness of outpatient surgical centers is appealing to both patients and payers, further promoting the use of these devices in ASCs. As more healthcare providers recognize the potential for effective stroke management in outpatient settings, this segment is expected to experience substantial growth in the neurothrombectomy devices market.

Specialty Clinics:

Specialty clinics are emerging as a notable end user of neurothrombectomy devices, providing focused treatment options for patients suffering from stroke-related complications. These clinics often concentrate on stroke rehabilitation and management, making them ideal settings for the application of neurothrombectomy devices. The increasing awareness among patients regarding the availability of specialized care is driving the growth of this segment. Specialty clinics typically offer advanced treatment options, including neurothrombectomy, which is critical for improving patient outcomes. Additionally, the collaboration between specialty clinics and hospitals enhances the continuum of care for stroke patients, further promoting the use of neurothrombectomy devices. As the landscape of stroke care continues to evolve, the role of specialty clinics in this market is expected to expand significantly.

By Modality

Robotic Assisted Thrombectomy:

Robotic assisted thrombectomy is an innovative modality within the neurothrombectomy devices market, leveraging advanced robotics technology to enhance the precision and efficacy of thrombus removal procedures. The integration of robotic systems allows for greater control and accuracy during interventions, minimizing the risk of complications and improving patient outcomes. As robotic-assisted technologies continue to gain acceptance among medical professionals, the adoption of such modalities in neurothrombectomy procedures is expected to increase. The benefits of robotic assistance, such as reduced fatigue for operators and improved procedural efficiency, are driving hospitals and surgical centers to invest in this technology. Furthermore, ongoing research and clinical trials aimed at validating the effectiveness of robotic assisted thrombectomy are poised to solidify its position in the neurothrombectomy landscape.

Manual Thrombectomy:

Manual thrombectomy remains a widely utilized modality in the neurothrombectomy devices market, where practitioners rely on their expertise and skill to perform thrombus retrieval. Despite the technological advancements in robotic-assisted interventions, manual thrombectomy continues to be a preferred choice for many healthcare providers due to its simplicity and cost-effectiveness. The effectiveness of manual thrombectomy procedures has been well-established through extensive clinical experience, leading to continued confidence in its application. Additionally, manual thrombectomy allows for greater flexibility in complex cases where robotic assistance may not be feasible. Training and continuous education for healthcare professionals specializing in manual thrombectomy techniques are essential to maintaining high standards of care. As the demand for effective stroke interventions grows, the manual thrombectomy modality is expected to remain a vital component of the neurothrombectomy devices market.

By Region

The neurothrombectomy devices market exhibits significant regional variation, with North America holding the largest share due to a well-established healthcare infrastructure and a high prevalence of stroke cases. The region's emphasis on advanced medical technologies is driving the demand for neurothrombectomy devices, with hospitals and surgical centers investing in these innovative solutions. In 2023, North America accounted for over 40% of the global market share, generating approximately USD 600 million in revenue. The CAGR for the North American market is anticipated to remain robust at around 6.8%, driven by ongoing advancements in stroke care technologies and increased awareness among healthcare professionals regarding effective treatment options.

Europe represents the second-largest region in the neurothrombectomy devices market, accounting for nearly 30% of the global market share in 2023. The increasing incidence of strokes and the rising geriatric population in Europe are significant factors contributing to the growth of this market. Additionally, the region is witnessing substantial investments in healthcare infrastructure, fostering the adoption of advanced neurothrombectomy devices. Asia Pacific is expected to show the highest growth rate, with a CAGR of approximately 7.5% during the forecast period, driven by rising healthcare expenditures and increasing awareness regarding stroke management. As healthcare systems in emerging markets continue to evolve, the demand for neurothrombectomy devices is anticipated to grow significantly, creating lucrative opportunities for manufacturers.

Opportunities

The neurothrombectomy devices market is ripe with opportunities, particularly in developing regions where healthcare infrastructure is expanding rapidly. As more hospitals and surgical centers invest in advanced technologies to manage acute ischemic strokes, the demand for neurothrombectomy devices is poised to increase significantly. The rising awareness among healthcare providers about the efficacy of these devices in improving patient outcomes is further driving this demand. Moreover, the surge in initiatives aimed at enhancing stroke care, such as training programs for medical professionals and public health campaigns to educate patients about stroke symptoms, is likely to result in increased utilization of neurothrombectomy devices. Another promising opportunity lies in the development of next-generation technologies that can provide more efficient, safer, and less invasive treatment options. Companies that invest in research and development to create innovative solutions tailored to the specific needs of stroke patients will likely gain a competitive edge in this growing market.

Additionally, the shift towards personalized medicine presents significant opportunities for growth in the neurothrombectomy devices market. As healthcare providers increasingly focus on tailoring treatments to individual patient needs, they will require devices that can accommodate various anatomical variations and clinical presentations. Manufacturers that can offer customizable neurothrombectomy solutions are well-positioned to capture a larger market share. Furthermore, collaborations between device manufacturers and healthcare institutions can lead to improved clinical practices and foster innovation within the field. As medical technology continues to evolve, opportunities for partnerships, acquisitions, and mergers will arise, allowing companies to expand their portfolios and enhance their market presence.

Threats

Despite the promising growth prospects of the neurothrombectomy devices market, certain threats could hinder its progress. One of the primary concerns is the potential for regulatory challenges that may arise as new devices are developed and introduced into the market. Regulatory bodies, particularly in regions like North America and Europe, impose stringent requirements for medical devices, which can lead to delays in product launches and increased costs for manufacturers. Furthermore, the competitive landscape is becoming increasingly crowded, with numerous companies vying for market share. This heightened competition can lead to price pressures, impacting profitability for manufacturers and potentially stifling innovation. Additionally, the rapid pace of technological advancements means that companies must continually invest in research and development to remain relevant, which can strain financial resources.

Another significant threat is the variability in stroke care practices across different regions and healthcare facilities. The lack of standardization in treatment protocols can result in inconsistent usage of neurothrombectomy devices, impacting overall market growth. The availability of skilled professionals trained in the use of these devices is also a concern, as the effectiveness of neurothrombectomy procedures heavily relies on the expertise of the medical staff performing them. The ongoing COVID-19 pandemic has also highlighted the vulnerabilities in healthcare systems globally, potentially diverting resources and attention away from stroke management initiatives. If healthcare providers continue to face challenges in maintaining routine care due to pandemic-related disruptions, the adoption of neurothrombectomy devices may slow. Lastly, the increasing focus on cost containment within healthcare systems may lead to limited reimbursement options for these devices, further complicating their market penetration.

Overall, while the neurothrombectomy devices market holds significant promise, addressing these threats will require strategic planning, collaboration, and continuous innovation from manufacturers and healthcare providers alike.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Penumbra, Inc.
• Stryker Corporation
• Terumo Corporation
• Johnson & Johnson
• MicroVention, Inc.
• Cerenovus (a subsidiary of Johnson & Johnson)
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Neuravi (a subsidiary of Johnson & Johnson)
• Vascular Solutions, Inc.
• Rapid Medical
• Hinged Devices
• Reflow Medical, Inc.

The competitive landscape of the neurothrombectomy devices market is characterized by the presence of numerous key players, each striving to establish a foothold in this rapidly growing sector. Major companies such as Medtronic, Boston Scientific, and Penumbra are investing heavily in research and development to innovate and enhance the functionalities of their neurothrombectomy devices. These companies are focusing on developing cutting-edge technologies that improve procedural efficiency and patient outcomes, such as advanced stent retrievers and aspiration devices. Furthermore, many of these players are entering strategic partnerships and collaborations with healthcare institutions to promote their products and conduct clinical studies, thereby enhancing their market presence. With the ongoing evolution of stroke treatment methodologies, the competitive landscape is expected to continue transforming.

Medtronic plc is one of the leading players in the neurothrombectomy devices market, renowned for its innovative product line that includes mechanical and aspiration devices. The company is focused on advancing the field of stroke care through continuous research and development, aiming to provide clinicians with state-of-the-art tools for effective intervention. Boston Scientific Corporation is another major contender, recognized for its commitment to developing minimally invasive solutions for stroke management. The company has developed a range of products targeting the neurothrombectomy market and is actively working to enhance its technology portfolio through ongoing innovation. Penumbra, Inc. specializes in neurovascular therapies, and its devices have garnered recognition for their effectiveness in treating acute ischemic strokes. The company's dedication to advancing stroke care options is evident through its continuous investment in research and new product development.

Another notable player is Stryker Corporation, which has established a strong presence in the neurothrombectomy devices market. Stryker's cutting-edge technologies and commitment to improving patient outcomes have positioned it as a trusted name in the healthcare sector. Terumo Corporation is also making significant strides by focusing on the development of specialized devices that cater to the unique needs of neurovascular intervention. The company is dedicated to enhancing its offerings through innovation and expanding its global reach. Additionally, companies like MicroVention, Asahi Intecc, and Cerenovus are playing a vital role in shaping the neurothrombectomy devices landscape, continuously striving to improve their product offerings and expand their market share. The competitive dynamics within this market are expected to intensify as newer players enter the field and existing companies enhance their capabilities.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Rapid Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hinged Devices
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Penumbra, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 MicroVention, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Terumo Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 AngioDynamics, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stryker Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Reflow Medical, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Asahi Intecc Co., Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Vascular Solutions, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Neuravi (a subsidiary of Johnson & Johnson)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cerenovus (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Neurothrombectomy Devices Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
  • 6.2 Neurothrombectomy Devices Sales Market, By Modality
    • 6.2.1 Robotic Assisted Thrombectomy
    • 6.2.2 Manual Thrombectomy
  • 6.3 Neurothrombectomy Devices Sales Market, By Application
    • 6.3.1 Acute Ischemic Stroke
    • 6.3.2 Chronic Stroke
  • 6.4 Neurothrombectomy Devices Sales Market, By Product Type
    • 6.4.1 Mechanical Devices
    • 6.4.2 Aspiration Devices
    • 6.4.3 Stent Retrievers
    • 6.4.4 Suction Devices
    • 6.4.5 Balloon Guide Catheters

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Neurothrombectomy Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Neurothrombectomy Devices Sales market is categorized based on

By Product Type

• Mechanical Devices
• Aspiration Devices
• Stent Retrievers
• Suction Devices
• Balloon Guide Catheters

By Application

• Acute Ischemic Stroke
• Chronic Stroke

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Modality

• Robotic Assisted Thrombectomy
• Manual Thrombectomy

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Penumbra, Inc.
• Stryker Corporation
• Terumo Corporation
• Johnson & Johnson
• MicroVention, Inc.
• Cerenovus (a subsidiary of Johnson & Johnson)
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Neuravi (a subsidiary of Johnson & Johnson)
• Vascular Solutions, Inc.
• Rapid Medical
• Hinged Devices
• Reflow Medical, Inc.